-+ 0.00%
-+ 0.00%
-+ 0.00%

TEVA AND FOSUN PHARMA ENTER INTO A STRATEGIC PARTNERSHIP TO DEVELOP NOVEL ANTI-PD1-IL2 THERAPY (TEV-56278) IN IMMUNO-ONCOLOGY

Reuters·06/16/2025 12:30:00

Please log in to view news